Pervasive Developmental Disorder Not Otherwise Specified
📧 Sign up to get email alerts when something new happens for Pervasive Developmental Disorder Not Otherwise Specified.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Cholesterol in ASD: Characterization and Treatment [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial investigated cholesterol-related aspects and potential treatment approaches in autism spectrum di…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Memantine in Adult Autism Spectrum Disorder [NA]
Clinical trial update shows memantine was tested in adults with autism spectrum disorders, but the study was terminated and results were pos…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: D-Cycloserine and Social Skills Training in Autism Spectrum Disorders [Phase 3]
Phase 3 trial evaluating D-Cycloserine in combination with social skills training for autism spectrum disorders has completed; results were …
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism [NA]
A completed clinical trial evaluated cognitive behavioral therapy for anxiety disorders in adolescents with autism, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) [Phase 2]
Phase 2 safety study of memantine in pediatric patients with autism spectrum disorders, including Asperger syndrome and PDD-NOS, was termina…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) [Phase 2]
An open-label Phase 2 safety study of memantine in pediatric patients with autism spectrum disorders has completed, with results posted in 2…